ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,095.20
      -1.09%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.64
      -0.17%
      Bitcoin
      65,892.45
      -0.05%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neumora Therapeutics Inc (NMRA)

      7. Neumora Therapeutics Inc (NMRA) Financials

      Neumora Therapeutics Inc

      Neumora Therapeutics Inc (NMRA)

      NASDAQ
      11.94
      0.33
      (2.84%)
      Closed July 24 4:00PM
      Delayed by 15 minutes
      12.46
      0.52
      (4.36%)
      After Hours: 5:58PM
      Delayed by 15 minutes

      Neumora Therapeutics Inc Financial Summary

      The current NMRA market cap is 1.99B. The company's latest EPS is USD -1.4789 and P/E is -8.06.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -56.86M-114M-60.07M
      Net Income -53.03M-108.73M-53.72M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -237.32M-135.87M-252.1M
      Net Income -237.31M-130.9M-235.93M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Assets 544.75M496.2M450.21M
      Total Liabilities 32.06M27.12M25.67M
      Total Equity 512.69M469.08M424.54M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 429.3M426.23M496.2M
      Total Liabilities 24.66M29.4M27.12M
      Total Equity -325.22M-446.85M469.08M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Operating -111.84M-163.28M-42.96M
      Investing 50.71M64.39M-150M
      Financing 232.42M231.94M1.85M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -75.42M-114.9M-163.28M
      Investing -817k-168.01M64.39M
      Financing 293.51M115.74M231.94M

      Stats and Ratios

      Market Cap 1.99B
      Price to Earnings Ratio -8.06
      Price to Sales Ratio 0
      Price to Cash Ratio 5.08
      Price to Book Ratio 4.05
      Dividend Yield -

      Share Statistics

      Shares Outstanding 159.52M
      Average Volume (1 week) 606.66k
      Average Volume (1 Month) 807.54k
      52 Week Change -24.48%
      52 Week High 21.00
      52 Week Low 8.33
      Spread (Intraday) 1.04 (8.35%)

      Company Info

      Company Name Neumora Therapeutics Inc
      Address 1209 orange street
      new castle, delaware
      Website https://www.neumoratx.com.
      Industry biological pds,ex diagnstics (2836)